Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

NOT GOOD FOR SHAREHOLDERS: Being vague on progress must be a strategic decision within the company.

Pretty obvious that they neglected—yet again—to update the FDA website status.

While the patience crowd probably is 100% OK with this, I think it is the only real flaw of how the company has been run. The stock is terribly undervalued if what we have is real.

Every time I see another long-term shareholder talking about not making it, I think of Benny. I also think of those who suffer needlessly if we really have a treatment.

That's a lot of casualties on this road to glory. Time is a resource just like money or science, and it seems like the Company doesn't care that much about wasting time.

Right now, the only thing we have on the horizon to drive the stock price higher is a surprise accelerated approval for Rett in 1st half 2022. Alz data given the track record won't show up until 2033, and approval might take until 2024. the Company has to figure out how to get this done faster.